Khoronenko V É, Donskova Iu S, Baskakov D S, Drozhzhina O V, Sidorov D V, Lozhkin M V, Petrov L O, Nemtsova E R, Iakubovskaia R I
Anesteziol Reanimatol. 2014 Jul-Aug;59(4):33-8.
The article deals with a problem of prophylaxis of hepatic insufficiency in oncological patients after liver resections.
We analyzed data of effectiveness and safety of the use of Remaxol in oncological patients with hepatic metastasis of colorectal cancer--dynamics of indicators of cytolysis and cholestasis, hepatic protein synthesis, exchange of pigments, pro- and antioxidant system and the level of endogen intoxication in postoperative period.
Use of Remaxol allows decreasing the duration of postoperative rehabilitation and intensive care unit staying.
本文探讨了肝癌切除术后肿瘤患者肝衰竭的预防问题。
我们分析了瑞马唑仑在结直肠癌肝转移肿瘤患者中的有效性和安全性数据——术后细胞溶解和胆汁淤积指标、肝蛋白合成、色素代谢、抗氧化系统及内源性中毒水平的动态变化。
使用瑞马唑仑可缩短术后康复和重症监护病房停留时间。